The Opioid Epidemic and Pain Medicine Specialists: Where to Begin and What Is Next?

REFERENCES

1. ↵
   1. Hirschfeld Davis J.

   Trump declares opioid crisis a ‘health emergency' but requests no funds. The New York Times. October 26, 2017.https://www.nytimes.com/2017/10/26/us/politics/trump-opioid-crisis.html. Accessed January 17, 2017.
2. ↵
   Express Scripts Lab. A nation in pain: focusing on U.S. opioid trends for treatment of short-term and longer-term pain: an Express Scripts report. December 2014.http://lab.express-scripts.com/lab/publications/a-nation-in-pain. Accessed December 13, 2017.
3. ↵
   International Narcotics Control Board. Availability of Internationally Controlled Drugs: Ensuring Adequate Access for Medical and Scientific Purposes: Indispensable, Adequately Available and not Unduly Restricted. Vienna, Austria: International Narcotics Control Board; 2015. http://www.incb.org/documents/Publications/AnnualReports/AR2015/English/Supplement-AR15_availability_English.pdf. Accessed January 18, 2018.
4. ↵
   1. Brown RE Jr.,
   2. Sloan PA.

   The opioid crisis in the United States: chronic pain physicians are the answer, not the cause. Anesth Analg. 2017 11; 125 5: 1432- 1434. doi: 10.1213/ANE.0000000000002417. pmid:29049104

   OpenUrlCrossRefPubMed
5. ↵
   1. Guy GP Jr.,
   2. Zhang K.,
   3. Bohm MK.,
   4. et al.

   Vital signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017 7 7; 66 26: 697- 704. doi: 10.15585/mmwr.mm6626a4. pmid:28683056

   OpenUrlCrossRefPubMed
6. ↵
   1. Warner M.,
   2. Chen LH.,
   3. Makuc DM.,
   4. Anderson RN.,
   5. Miniño AM.

   Drug poisoning deaths in the United States, 1980-2008. NCHS Data Brief. 2011 12; 81:1-8.
7. ↵
   1. Hedegaard H.,
   2. Warner M.,
   3. Minino AM.

   Drug overdose deaths in the United States, 1999-2015. NCHS Data Brief. 2017 2; 273:1-8.
8. ↵
   1. Manchikanti L.,
   2. Helm S 2nd.,
   3. Fellows B.,
   4. et al.

   Opioid epidemic in the United States. Pain Physician. 2012 7; 153 Suppl:ES9-ES38. pmid:22786464

   OpenUrlPubMed
9. ↵
   1. Chou R.,
   2. Turner JA.,
   3. Devine EB.,
   4. et al.

   The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015 2 17; 162 4: 276- 286. doi: 10.7326/M14-2559. pmid:25581257

   OpenUrlCrossRefPubMed
10. ↵
    1. Ballantyne JC.

    Opioids for the treatment of chronic pain: mistakes made, lessons learned, and future directions. Anesth Analg. 2017 11; 125 5: 1769- 1778. doi: 10.1213/ANE.0000000000002500. pmid:29049121

    OpenUrlCrossRefPubMed
11. ↵
    1. Kroenke K.,
    2. Cheville A.

    Management of chronic pain in the aftermath of the opioid backlash. JAMA. 2017 6 20; 317 23: 2365- 2366. doi: 10.1001/jama.2017.4884. pmid:28494058

    OpenUrlCrossRefPubMed
12. ↵
    1. Haymond S.,
    2. Nagpal G.,
    3. Heiman H.

    Urine drug screens to monitor opioid use for managing chronic pain. JAMA. 2017 9 19; 318 11: 1061- 1062. doi: 10.1001/jama.2017.10593. pmid:28975284

    OpenUrlCrossRefPubMed
13. ↵
    1. Knezevic NN.,
    2. Khan OM.,
    3. Beiranvand A.,
    4. Candido KD.

    Repeated quantitative urine toxicology analysis may improve chronic pain patient compliance with opioid therapy. Pain Physician. 2017 2; 20 2S: S135- S145. pmid:28226335

    OpenUrlPubMed
14. ↵
    1. Krishnamurthy P.,
    2. Ranganathan G.,
    3. Williams C.,
    4. Doulatram G.

    Impact of urine drug screening on no shows and dropouts among chronic pain patients: a propensity-matched cohort study. Pain Physician. 2016 2; 19 2: 89- 100. pmid:26815253

    OpenUrlPubMed
15. ↵
    1. Dowell D.,
    2. Haegerich TM.,
    3. Chou R.

    CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016 4 19; 315 15: 1624- 1645. doi: 10.1001/jama.2016.1464. pmid:26977696

    OpenUrlCrossRefPubMed
16. ↵
    1. Manchikanti L.,
    2. Kaye AM.,
    3. Knezevic NN.,
    4. et al.

    Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician. 2017 2; 20 2S: S3- S92. pmid:28226332

    OpenUrlPubMed
17. ↵
    Institute of Medicine Committee on Advancing Pain Research, Care, and Education. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: National Academies Press; 2011. https://www.uspainfoundation.org/wp-content/uploads/2016/01/IOM-Full-Report.pdf. Accessed January 18, 2018.
18. ↵
    1. Mackey S.

    National Pain Strategy Task Force: the strategic plan for the IOM Pain Report. Pain Med. 2014 7; 15 7: 1070- 1071. doi: 10.1111/pme.12490. pmid:25059928

    OpenUrlCrossRefPubMed
19. ↵
    National Institutes of Health Interagency Pain Research Coordinating Committee. National Pain Strategy: A Comprehensive Population Health-Level Strategy for Pain. March 18, 2016. https://iprcc.nih.gov/sites/default/files/HHSNational_Pain_Strategy_508C.pdf. Accessed January 18, 2018.